GlassScriptPhysician profile
John B Ammori
NPI 1902926751
$5,855.31
in general payments reported to CMS, 2019-2025
18 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $346 · 2020: $47.38 · 2021: $139 · 2022: $3,168 · 2023: $873 · 2024: $539 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,974 · Education: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,973.67 |
| Education | $182.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,701.00 | 2019-2025 | Da Vinci Surgical System |
| Aroa Biosurgery Incorporated | $538.98 | 2022-2025 | |
| Davol INC. | $430.76 | 2019-2024 | Arista Ah Flexitip |
| Tela Bio, INC. | $307.35 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Boston Scientific Corporation | $247.06 | 2022-2025 | Spyglass Discover |
| Medical Device Business Services, INC. | $233.66 | 2022-2023 | |
| Inari Medical, INC. | $206.04 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kerecis Limited | $193.39 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $164.53 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $142.23 | 2022 | |
| Haemonetics Corporation | $124.04 | 2025 | Teg6s Hemostasis System |
| La Jolla Pharmaceutical Company | $123.34 | 2023 | Xerava |
| Medtronic, INC. | $105.99 | 2024 | Ligasure |
| Kci USA, INC. | $100.16 | 2023 | Abthera, V.A.C. Veraflo |
| Ethicon US, LLC | $91.64 | 2019-2023 | Certus 140 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intera Oncology, INC | $74.02 | 2025 | Intera |
| Teleflex LLC | $54.32 | 2019 | |
| Aveo Pharmaceuticals, INC. | $16.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ammori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.